HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care.

AbstractBACKGROUND AND AIMS:
Sex differences in cardiovascular prevention have been reported, yet the role of sex with regard to different modifiable risk factors such as low-density lipoprotein cholesterol (LDL-C), systolic blood pressure (BP), and glycated hemoglobin (HbA1c) in primary care settings is unclear. Therefore, we studied sex differences in assessment and measured values of LDL-C, BP, and HbA1c in primary and secondary cardiovascular prevention delivered by general practitioners.
METHODS:
This cross-sectional study was based on electronic medical records of 59,092 primary care patients (51.9% women) aged 40-79 years in Switzerland. Multilevel regression was used to model associations of sex with assessment and measured values of LDL-C, BP, and HbA1c in 2018.
RESULTS:
In both primary and secondary prevention, women had lower LDL-C assessment rates (age-adjusted odds ratio (aOR) 0.71 [95% confidence interval (CI) 0.67 to 0.75] and 0.70 [CI 0.51 to 0.95]), and higher measured LDL-C values than men (age-adjusted difference 0.30 mmol/L [CI 0.25 to 0.35] and 0.28 mmol/L [CI 0.07 to 0.48]). Compared with men, women in primary prevention displayed lower BP and HbA1c assessment frequencies (aOR 0.77 [CI 0.73 to 0.81] and 0.76 [CI 0.71 to 0.80]) and measured values (age-adjusted difference -2.49 mmHg [CI -2.99 to -1.79] and -0.19% [CI -0.24 to -0.14]), while there was no sex difference in secondary prevention. Age-dependent increases in measured values of LDL-C, BP, and HbA1c were greater in women than men.
CONCLUSIONS:
Control of LDL-C in women in primary care should be improved to reduce sex-based inequalities in prevention of cardiovascular disease.
AuthorsYael Rachamin, Thomas Grischott, Thomas Rosemann, Matthias R Meyer
JournalAtherosclerosis (Atherosclerosis) Vol. 324 Pg. 141-147 (05 2021) ISSN: 1879-1484 [Electronic] Ireland
PMID33810858 (Publication Type: Journal Article)
CopyrightCopyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Cholesterol, LDL
Topics
  • Adult
  • Aged
  • Cardiovascular Diseases (diagnosis, epidemiology, prevention & control)
  • Cholesterol, LDL (blood)
  • Cross-Sectional Studies
  • Female
  • Heart Disease Risk Factors
  • Humans
  • Male
  • Middle Aged
  • Primary Health Care
  • Risk Factors
  • Sex Factors
  • Switzerland (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: